Do Uterine Fibroids Shrink Before or After Menopause?
At a Glance
Uterine fibroids most often stabilize or shrink after menopause as estrogen and progesterone levels fall, but not always. Before menopause, their growth is unpredictable, and any new bleeding or enlarging mass after menopause needs prompt medical evaluation.
In this answer
4 sections
Yes, uterine fibroids usually shrink naturally after menopause, but this is not guaranteed for everyone. Because fibroids are sensitive to reproductive hormones (estrogen and progesterone), their growth typically slows or reverses when major ovarian hormone levels fall during menopause [1][2]. However, before menopause, their growth is highly unpredictable [3]. Because of this, waiting for menopause is not always a realistic strategy if you are experiencing severe symptoms. Additionally, if you experience new growth or bleeding after menopause, it requires prompt medical evaluation—not panic, but careful assessment to rule out other conditions [4][5].
(Note: Menopause is officially defined as going 12 consecutive months without a menstrual period.)
Before Menopause: The Hormone-Dependent Years
During your reproductive years, your ovaries produce estrogen and progesterone. These hormones act as a major fuel source for uterine fibroids, promoting their survival and growth [1][6].
The pace of this growth is highly variable. Fibroids do not grow at a steady, predictable rate. Research shows that annual changes in fibroid size before menopause can range anywhere from substantial shrinkage to very large increases in volume [3]. Even two different fibroids within the same uterus can behave entirely differently [7]. Because of this unpredictability, doctors cannot guarantee that a fibroid will stay small or grow slowly while you wait for menopause. Treatment decisions often involve weighing options like observation, medication, or surgery against how much your symptoms impact your life.
After Menopause: What Usually Happens
When you enter menopause, your ovaries produce significantly less estrogen and progesterone. With this drop in hormone levels, the most common pattern is for fibroids to stabilize and shrink [8][2].
However, regression is not inevitable. While most fibroids shrink, some persist at their current size, and a small subset may even continue to grow [8][9]. Factors that can influence postmenopausal fibroid behavior include:
- Obesity: Fat tissue can produce peripheral estrogen, which is associated with continued fibroid growth after menopause in some patients [9].
- Hormone Replacement Therapy (HRT): Systemic menopausal hormone therapy can sometimes maintain or increase fibroid size, but the effects vary by the specific regimen and the patient. Having fibroids does not automatically mean you cannot use HRT. If you choose to take it, your doctor will individualize your care and monitor your symptoms to ensure the therapy remains appropriate for you [10][11].
Why Symptoms Might Persist Despite Menopause
Even if a fibroid shrinks after menopause, you might still experience symptoms like pelvic pressure, urinary frequency, or bowel issues. Shrinkage often improves these symptoms, but they can persist for a few reasons:
- Rigid Structure: Fibroids contain dense, rigid tissue called the extracellular matrix [12]. Much like stiff scar tissue, this structure is one reason a fibroid can remain somewhat bulky and continue to press on your bladder, bowel, or pelvic floor even after hormone levels drop [13][14].
- Degeneration: Sometimes, as a fibroid loses its blood supply and shrinks, the tissue begins to break down. This process, called fibroid degeneration, can cause pelvic pain [15][16]. However, new or severe pain after menopause can also stem from ovarian, urinary, or bowel conditions, so it always requires professional assessment.
Red Flags: When to Seek Prompt Care
A critical rule of postmenopausal health is that new growth or new bleeding should never be brushed off as “just a fibroid” [5]. While fibroids can sometimes contribute to bleeding or pain, these symptoms can also point to other conditions.
- Postmenopausal Bleeding: Any bleeding after 12 months without a period is considered abnormal. Your doctor will investigate this just as they would for someone without fibroids. The evaluation may include a transvaginal ultrasound or an endometrial biopsy (a small sample of the uterine lining) to rule out conditions like polyps or endometrial cancer (cancer of the uterine lining) [5][17][18].
- Rapid Growth: A newly enlarging uterine mass after menopause requires prompt evaluation. While it could be a benign (non-cancerous) fibroid, doctors must also consider a rare cancer of the uterine muscle called a leiomyosarcoma [4][19]. A benign fibroid does not typically “turn into” this cancer, but the two can look similar on imaging. While an ultrasound or MRI can help characterize the mass, no imaging test can reliably rule cancer in or out; definitive diagnosis generally requires examining the tissue in a pathology lab, often after surgical removal [20][4].
When to Seek Urgent Care: Contact a doctor promptly for any new bleeding or newly enlarging mass. Seek urgent or emergency care if you experience heavy bleeding, fainting, marked dizziness, severe or rapidly worsening pain, or a high fever.
Common questions in this guide
Do uterine fibroids usually get smaller after menopause?
Can a fibroid shrink or grow before I reach menopause?
Is bleeding after menopause normal if I already have fibroids?
What should I do if a fibroid or uterine mass grows after menopause?
Can menopause hormone therapy make fibroids grow?
Why might I still have pelvic pressure or pain after a fibroid shrinks?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on uterine corpus leiomyoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current age and symptoms, is watchful waiting until menopause a safe and realistic option for my fibroids, or should we discuss treatments like medication or minimally invasive procedures?
- 2.If I decide to use hormone replacement therapy (HRT) for my menopause symptoms, how will we manage the potential effects on my fibroids?
- 3.What specific evaluation will we use to determine whether my new pelvic pain or pressure is related to my existing fibroids or another condition?
- 4.Given my personal risk factors, what exact steps will we take if I experience any spotting or bleeding after menopause?
References
References (20)
- 1
UTERINE FIBROIDS.
Bulun SE, Yin P, Wei J, et al.
Physiological reviews 2025; (105(4)):1947-1988 doi:10.1152/physrev.00010.2024.
PMID: 40214304 - 2
Uterine Fibroids: Diagnosis and Treatment.
De La Cruz MS, Buchanan EM
American family physician 2017; (95(2)):100-107.
PMID: 28084714 - 3
Rapidly growing uterine myoma - should we be afraid of it?
Nowak M, Bartosik W, Witana W, et al.
Przeglad menopauzalny = Menopause review 2023; (22(3)):161-164 doi:10.5114/pm.2023.131497.
PMID: 37829270 - 4
Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman.
Ainsworth AJ, Dashti NK, Mounajjed T, et al.
Diagnostic pathology 2019; (14(1)):32 doi:10.1186/s13000-019-0809-1.
PMID: 31027501 - 5
The management of uterine leiomyomas.
Lefebvre G, Vilos G, Allaire C, et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2003; (25(5)):396-418; quiz 419-22.
PMID: 12738981 - 6
Progesterone and estrogen signaling in uterine fibroids: A tale of two interconnected pathways.
Saini K, Singh S, Garg N
The Journal of steroid biochemistry and molecular biology 2026; (262()):107036 doi:10.1016/j.jsbmb.2026.107036.
PMID: 42102980 - 7
Analysis of MED12 Mutation in Multiple Uterine Leiomyomas in South Korean patients.
Lee M, Cheon K, Chae B, et al.
International journal of medical sciences 2018; (15(2)):124-128 doi:10.7150/ijms.21856.
PMID: 29333096 - 8
Uterine Leiomyomas Across the Menopausal Transition.
Encalada-Soto D, Hochberg LS, Laughlin-Tommaso S
Obstetrics and gynecology 2026; doi:10.1097/AOG.0000000000006339.
PMID: 42241706 - 9
Growth of surgically confirmed leiomyomas in postmenopausal women: analysis of the influencing factors.
Shen M, Duan H, Chang Y, Wang S
Menopause (New York, N.Y.) 2021; (28(11)):1209-1213 doi:10.1097/GME.0000000000001846.
PMID: 34469931 - 10
The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
Moro E, Degli Esposti E, Borghese G, et al.
Medicina (Kaunas, Lithuania) 2019; (55(9)) doi:10.3390/medicina55090549.
PMID: 31480288 - 11
Hormone therapy in menopausal women with fibroids: is it safe?
Srinivasan V, Martens MG
Menopause (New York, N.Y.) 2018; (25(8)):930-936 doi:10.1097/GME.0000000000001105.
PMID: 29613885 - 12
Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS, Ciavattini A, Petraglia F, et al.
Human reproduction update 2018; (24(1)):59-85 doi:10.1093/humupd/dmx032.
PMID: 29186429 - 13
Urological complications of uterine leiomyoma: a review of literature.
Dagur G, Suh Y, Warren K, et al.
International urology and nephrology 2016; (48(6)):941-8 doi:10.1007/s11255-016-1248-5.
PMID: 26922066 - 14
Improvement in parameters of quality of life and uterine volume reduction after uterine fibroid embolization.
Silva NACD, Szejnfeld D, Klajner RK, et al.
Einstein (Sao Paulo, Brazil) 2020; (18()):eAO5458 doi:10.31744/einstein_journal/2020AO5458.
PMID: 32965299 - 15
Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma.
Tanioka S, Asano R, Wakabayashi R, et al.
BMC women's health 2022; (22(1)):346 doi:10.1186/s12905-022-01924-6.
PMID: 35974345 - 16
Fibroid degeneration in a postmenopausal woman presenting as an acute abdomen.
Shrestha R, Khanal R, Aryal MR, et al.
Journal of community hospital internal medicine perspectives 2015; (5(1)):25917 doi:10.3402/jchimp.v5.25917.
PMID: 25656665 - 17
Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
Ferrinho C, Silva E, Oliveira M, Sequeira Duarte J
BMJ case reports 2021; (14(3)) doi:10.1136/bcr-2020-240937.
PMID: 33731391 - 18
ACOG Committee Opinion No. 734 Summary: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.
Obstetrics and gynecology 2018; (131(5)):945-946 doi:10.1097/AOG.0000000000002626.
PMID: 29683904 - 19
Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis.
Lin Y, Wu RC, Huang YL, et al.
Abdominal radiology (New York) 2022; (47(6)):2197-2208 doi:10.1007/s00261-022-03431-6.
PMID: 35347386 - 20
Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper.
Laganà AS, Romano A, Vanhie A, et al.
Gynecologic and obstetric investigation 2024; (89(2)):73-86 doi:10.1159/000537730.
PMID: 38382486
This page explains how uterine fibroids may change around menopause for informational purposes only and does not replace medical advice. New bleeding, pain, or growth after menopause should be evaluated by a qualified clinician.